MedTrace Logo

Genetic Susceptibility Factors for Candidemia.

NCT02841501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 453

Last updated 2021-03-26

No results posted yet for this study

Summary

This is a prospective case-control physiopathological study, which main objective is to determine the genetic host factors predisposing to candidemia. Secondary objectives are to develop new diagnosis tools using the biological collection, to describe and update epidemiology, to analyse the influence of genetic polymorphisms on prognosis.

Conditions

  • Invasive Candidiasis
  • Candidemia
  • Genetic Predisposition to Disease

Interventions

GENETIC

Analysis of genetic polymorphisms

An analysis of the SNPs (single nucleotide polymorphism) of 25 candidate genes will be performed. This analysis will be completed by a genome wide association study.

Sponsors & Collaborators

  • Seventh Framework Programme

    collaborator OTHER

  • University of Lausanne Hospitals

    collaborator OTHER

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Julien Poissy, MD, PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2020-06-25
Completion
2020-06-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02841501 on ClinicalTrials.gov